Xiaoyan Bai | Nephrology | Outstanding Scientist Award

Published on by China Scientist

Prof. Dr. Xiaoyan Bai | Nephrology | Outstanding Scientist Award

Professor Xiaoyan Bai is a Professor of Nephrology at Guangdong Provincial People’s Hospital and Southern Medical University, where she also serves as Vice Dean of the Graduate School at Guangdong Medical University. She earned her medical and doctoral degrees in Pathology and completed her postdoctoral training at the University of Texas Southwestern Medical Center in the United States. Her research focuses on the molecular mechanisms of diabetic nephropathy, podocyte injury, and renal fibrosis, with a strong emphasis on translating discoveries into therapeutic strategies. She has published widely in high-impact journals, received provincial recognition for scientific advancement, and leads multiple national research projects while mentoring future scholars.

Prof. Dr. Xiaoyan Bai | Guangdong Provincial People’s Hospital | China

Profile

SCOPUS

Education

  • Professor Xiaoyan Bai holds both a Doctor of Medicine and a Doctor of Philosophy in Pathology. She further advanced her academic journey by completing postdoctoral training at the University of Texas Southwestern Medical Center in the United States. Her strong educational foundation in clinical and molecular medicine has guided her research in nephrology, particularly in the fields of diabetic kidney disease and renal fibrosis.

Experience

  • She currently serves as a Professor of Nephrology at Guangdong Provincial People’s Hospital and Guangdong Academy of Medical Sciences, affiliated with Southern Medical University. In addition, she holds the position of Vice Dean at the Graduate School of Guangdong Medical University. Beyond her academic appointments, she actively engages in leading and supervising doctoral students while managing key national and provincial research projects. Her experience is also enriched through collaborations with international institutions, such as UT Southwestern Medical Center, and through her involvement in peer review for leading journals.

Awards and Recognition

  • Professor Bai has been recognized with significant scientific honors, including the First Prize for Scientific and Technological Advancement from Guangdong Province. This award highlights her impactful contributions to understanding the mechanisms underlying diabetic nephropathy and kidney fibrosis.

Skills and Expertise

  • She possesses expertise in experimental pathology, molecular biology, and translational nephrology research. Her skills extend to leading large-scale research projects, supervising postgraduate training, and publishing in high-impact international journals. Additionally, she has experience in industry collaborations, patent development, and academic writing. Her editorial contributions and peer-review activities for international journals also demonstrate her critical evaluation skills and leadership in the field of kidney disease research.

Research Focus 

  • Her primary research interests center on the molecular mechanisms of diabetic nephropathy, podocyte injury, renal tubulointerstitial fibrosis, and hypertensive kidney damage. She explores novel therapeutic pathways and potential drug targets, with a strong emphasis on bridging molecular mechanisms to clinical treatment strategies.

Publications

  • Flot2 protects against podocyte injury by maintaining the stability of synaptopodin in diabetic nephropathy,  Metabolism: Clinical and Experimental, 2025

  • Effectiveness and safety of finerenone in membranous nephropathy patients: a retrospective, real-world study, International Urology and Nephrology, 2025

  • The roles and functions of TMEM protein family members in cancers, cardiovascular and kidney diseases (Review), [Journal not shown in preview], 2025

  • Single-Cell Dissection of the Biological Function and Molecular Features Underlying the Micropeptide LSMEM1 in Kidney, Advanced Science, 2025

  • Single-cell transcriptome atlas in C57BL/6 mice encodes morphological phenotypes in the aging kidneys, BMC Nephrology, 2024

Conclusion

  • Professor Xiaoyan Bai stands out as a visionary leader in nephrology whose research has advanced the understanding of diabetic nephropathy, renal fibrosis, and kidney injury mechanisms. Her combination of scientific innovation, impactful publications, and commitment to mentorship and collaboration makes her a strong contender for the Research for Outstanding Scientist Award. With her continued focus on translational medicine and international engagement, she is well-positioned to shape the future of kidney disease research and improve patient outcomes worldwide.

Min Zhang | Nephrology | Best Researcher Award

Published on by China Scientist

Dr. Min Zhang | Nephrology | Best Researcher Award

 Cutting-Edge Research:

  • Dr. Zhang is at the forefront of nephrology research, focusing on disease mechanisms using multi-omics technology. Her ongoing projects, funded by major institutions like the National Natural Science Foundation of China, demonstrate her capability to secure competitive grants and her engagement with high-impact research.
Dr. Min Zhang, Department of Nephrology, First Medical Center of Chinese PLA General Hospital, China

Profile

Scopus

OrcID

🌱EARLY ACADEMIC PURSUITS

  • Dr. Min Zhang began her academic journey at the prestigious Tongji Medical College of Huazhong University of Science and Technology, where she earned her bachelor’s degree. She later pursued her doctoral studies at the Academy of Military Sciences, focusing on leveraging multi-omics technology to explore disease mechanisms. Her exemplary work earned her the Outstanding Doctoral Dissertation of the PLA award, a mark of distinction that set the foundation for her impactful career.

💼 PROFESSIONAL ENDEAVORS

  • Currently serving as an Attending Physician in the Department of Nephrology at the First Medical Center of Chinese PLA General Hospital, Dr. Zhang is committed to advancing nephrology and disease research through innovative approaches like single-cell sequencing. She has also been recognized as a young talent in China’s Association for Science and Technology’s Talent Lifting Program, an acknowledgment of her potential and early career achievements.

🔬 CONTRIBUTIONS AND RESEARCH FOCUS 

  • Dr. Zhang has published 19 SCI-indexed papers across reputable journals, such as GUT, Journal of Hepatology, Science Advances, and Molecular Therapy. Her research spans nephrology and single-cell sequencing, with a specific focus on applying multi-omics technology to understand disease development and progression. With 8 first-author papers and 5 co-corresponding author papers, she has become a leading voice in her field, contributing to groundbreaking insights in disease biology.

 📚 ACADEMIC CITES 

  • Dr. Zhang’s research excellence is reflected in multiple awards, including the Beijing Natural Science Award (second prize) and accolades for her dissertation work. She has also been named a Youth Member of the Smart Medical Professional Committee of the Chinese Association of Integrative Medicine, enhancing her profile as a respected thought leader in innovative medical research.

🌍 IMPACT AND INFLUENCE

  • Dr. Zhang’s work has garnered significant attention, with her research cited 850 times overall and her highest-cited paper receiving 360 citations. Notably, her contributions include 3 ESI highly cited papers and 1 F1000 recommended paper, underscoring her work’s influence within the scientific community. Her ability to address complex medical challenges has positioned her as a key contributor to both nephrology and integrative medical research.

🌟 LEGACY AND FUTURE AND CONTRIBUTIONS

  • Looking ahead, Dr. Zhang aims to deepen her contributions to nephrology through advanced, single-cell sequencing approaches and multi-omics studies. Her ongoing and completed research projects, including those funded by the National Natural Science Foundation of China (Grant No. 82203636) and the Young Talent Project of Chinese PLA General Hospital (20230403), highlight her commitment to tackling complex nephrological issues and contributing to the future of medical science.

📄Publications

  • “Comparison of preparation methods of rat kidney single-cell suspensions”
    Authors: Wang, T., Shen, W., Li, L., … Zhang, M., Chen, X.
    Journal: Scientific Reports, 2024, 14(1), 2785
  • “Highlighting immune features of the tumor ecosystem and prognostic value of Tfh and Th17 cell infiltration in head and neck squamous cell carcinoma by single-cell RNA-seq”
    Authors: Tian, Y., Liu, C., Yang, W., … Qin, Y., Wu, S.
    Journal: Cancer Immunology, Immunotherapy, 2024, 73(10), 187
  • “Treatment strategies with combined agency against severe viral pneumonia in patients with advanced cancer”
    Authors: Zhang, F., Li, T., Bai, Y., … Tao, H., Hu, Y.
    Journal: Journal of Translational Internal Medicine, 2024, 12(3), pp. 317–320
  • “Enhanced TRPC3 transcription through AT1R/PKA/CREB signaling contributes to mitochondrial dysfunction in renal tubular epithelial cells in D-galactose-induced accelerated aging mice”
    Authors: Wang, B., Yu, W., Zhang, W., … Chen, X., Chen, Y.
    Journal: Aging Cell, 2024, 23(6), e14130
  • “Cross-species single-cell analysis uncovers the immunopathological mechanisms associated with IgA nephropathy progression”
    Authors: Chen, X., Wang, T., Chen, L., … Zhang, M., Chen, X.
    Journal: JCI Insight, 2024, 9(9), e173651